Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bio Green Med Solution, Inc.CYCC · Entity 8225 | V.P., Clin. Dev. & Reg. Aff. | December 05, 2019 | December 10, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bio Green Med Solution, Inc.
Report date December 05, 2019 · Filed December 10, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.74 · Expires 2027-12-29 | Direct | 11,067 |
Reported balance
After 2019-12-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-12-05 · Grant · Acquired 11,067 · Balance 11,067 F1: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,067 shares. |
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.56 · Expires 2028-02-22 | Direct | 10,182 |
Reported balance
After 2019-12-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-12-05 · Grant · Acquired 10,182 · Balance 10,182 F2: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 10,182 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,067 shares.
F2: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 10,182 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2019 Filed Dec 10, 2019 02:01 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantOption · Derivative | 10,182 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001104659-19-071121 · tm1924755d3_4.xml · derivative · entry 2 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,182 Underlying: Common Stock · 10,182 shares Expires 2028-02-22 F2 · price: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 10,182 shares. F2 · derivative.exercise_date: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 10,182 shares. Read SEC document |
| December 05, 2019 Filed Dec 10, 2019 02:01 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantOption · Derivative | 11,067 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001104659-19-071121 · tm1924755d3_4.xml · derivative · entry 1 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,067 Underlying: Common Stock · 11,067 shares Expires 2027-12-29 F1 · price: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,067 shares. F1 · derivative.exercise_date: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,067 shares. Read SEC document |
| January 04, 2019 Filed Jan 7, 2019 14:27 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantOption · Derivative | 284,592 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001144204-19-000789 · tv510489_4.xml · derivative · entry 1 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,592 Underlying: Common Stock · 284,592 shares Expires 2029-01-04 F2 · price: These securities were granted as part of the Issuer's annual compensation review to executive officers. F1 · derivative.exercise_date: These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 14:27 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantOption · Derivative | 10,183 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001144204-19-000789 · tv510489_4.xml · derivative · entry 3 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,183 Underlying: Common Stock · 10,183 shares Expires 2028-02-22 F4 · price: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 10,183 shares. F4 · derivative.exercise_date: On February 22, 2018, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 10,183 shares. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 14:27 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantOption · Derivative | 11,068 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001144204-19-000789 · tv510489_4.xml · derivative · entry 2 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,068 Underlying: Common Stock · 11,068 shares Expires 2027-12-29 F3 · price: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 11,068 shares. F3 · derivative.exercise_date: On December 29, 2017, Judy Chiao was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 11,068 shares. Read SEC document |
| January 25, 2013 Filed Apr 12, 2018 21:30 UTC Amendment | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock, $0.001 par value per share | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-020331 · tv490979_form4a.xml · nonDerivative · entry 2 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,024 F1 · balance_after: An additional 16,428 shares, or 1,369 shares after taking into account the one-for-twelve reverse stock split that took effect in May 2016, were inadvertently added to the reporting person's original Form 4 and to all subsequent Forms 4. Read SEC document |
| January 25, 2013 Filed Apr 12, 2018 21:30 UTC Amendment | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock, $0.001 par value per share | 5,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-020331 · tv490979_form4a.xml · nonDerivative · entry 1 Chiao Judy · CIK 0001357601 · V.P., Clin. Dev. & Reg. Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,692 F1 · balance_after: An additional 16,428 shares, or 1,369 shares after taking into account the one-for-twelve reverse stock split that took effect in May 2016, were inadvertently added to the reporting person's original Form 4 and to all subsequent Forms 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.